NEW YORK, March 28, 2018 -- Progyny, the leading fertility benefits management company, announced today its sponsorship of National Infertility Awareness Week® (NIAW) from April 22nd to April 28th and Night of Hope, hosted and organized by RESOLVE: The National Infertility Association.
“RESOLVE has been a leading advocate for those suffering with infertility and we are thrilled and honored to be working with RESOLVE as an official sponsor of their events,” said David Schlanger, CEO of Progyny. “Together, we continue to drive awareness around the barriers to care and the importance of employer-sponsored coverage for fertility treatment.”
“With infertility impacting one in eight people, it’s imperative we provide patients with access to care like we do for every other medical condition and disease,” said Barbara Collura, President and CEO of RESOLVE. “We are thrilled to have Progyny as a partner for NIAW and Night of Hope.”
Progyny will be releasing resources during National Infertility Awareness Week to support infertility patients, and their employers, and bring general awareness around the topic.
To learn more about Progyny, visit www.progyny.com, to learn more about National Infertility Awareness Week visit www.infertilityawareness.org, and to learn more about RESOLVE, visit www.resolve.org.
About Progyny:
Progyny is a leading fertility benefits management company that combines clinical and emotional guidance, science, technology and data to provide comprehensive value-based fertility solutions for self-insured employers.
Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.
NEWS RELEASE
Media Contact: Selena Yang
[email protected]
Phone: 646-768-9719


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



